Physician profile
Gregory E Giles
NPI 1114931250
$3,186.64
in general payments reported to CMS, 2019-2025
13 companies · $388 in 2025
The $388 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $17.51 · 2020: $186 · 2021: $459 · 2022: $784 · 2023: $615 · 2024: $737 · 2025: $388.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,634 · Entertainment: $106.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,633.67 |
| Entertainment | $106.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $852.76 | 2022-2025 | Infuse, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $633.16 | 2020-2021 | |
| Alcon Vision LLC | $358.73 | 2022-2025 | Wavelight Ex500 Excimer Laser, Wavelight Refractive Suite, Ilux |
| Coopervision INC. | $281.43 | 2022-2025 | Myday Contact Lens, Synergeyes Contact Lens, Misight Contact Lens |
| Glaukos Corporation | $241.55 | 2022-2024 | Idose |
| Johnson & Johnson Vision Care, INC. | $179.01 | 2020-2023 | Acuvue |
| Sight Sciences, INC. | $148.14 | 2023 | Omni Surgical System |
| Amgen INC. | $142.23 | 2024 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $138.16 | 2025 | Xdemvy |
| Optos, INC. | $106.06 | 2024 | Oct Ophthalmoscope, Panoramic Ophthalmoscope, Nfc-700 |
| Biotissue Holdings INC. | $42.51 | 2019-2024 | |
| Abbvie INC. | $34.08 | 2022 | |
| Lombart Brothers, INC. | $28.82 | 2024 | Opd-III |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gregory Giles listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.